Mr. George Achilleos reports

NETRAMARK APPOINTS FORMER GLOBAL ATLANTIC INVESTMENT OFFICE PRESIDENT AND SCOTIABANK U.S. CEO KEVIN FELIX AS STRATEGIC ADVISOR

Netramark Holdings Inc. has appointed Kevin Felix as strategic adviser, strengthening the senior strategic and institutional experience surrounding the company as Netramark advances its commercialization strategy.

Mr. Felix brings more than 25 years of senior leadership experience across capital markets, asset management, corporate strategy and securities law. Most recently, Mr. Felix served as president of the Investment Office of Global Atlantic Financial Group, responsible for all business management and operational matters related to the firm's $175-billion investment portfolio. Prior thereto, his senior positions at Scotiabank included president and chief executive officer of Scotia Capital (USA) Inc. and global head of fixed income, currencies and commodities, a diverse multibillion dollar business throughout North and South America, Europe, and Asia. Mr. Felix also brings extensive corporate governance experience, having served as independent director for several firms.

"Kevin has operated at a high level within the global financial markets," said George Achilleos, chief executive officer of Netramark. "As we advance commercialization and broaden the company's relationships across the pharmaceutical and investment communities, we are continuing to strengthen the level of experience around the organization. Kevin is an exceptional addition."

"Netramark has developed a highly differentiated approach to applying artificial intelligence to one of the pharmaceutical industry's most significant challenges: understanding patient heterogeneity within clinical trials," said Mr. Felix, strategic adviser to Netramark. "I am excited to work with George and the Netramark team as they continue building the company, developing important industry relationships, and evaluating the strategic and capital markets opportunities that may accompany its growth."

Supporting Netramark's next stage of growth

As strategic adviser, Mr. Felix will advise Netramark on various matters, including Canadian and U.S. institutional investor and investment banking relationships, strategic transactions, corporate development, and longer-term capital markets strategy.

Mr. Felix holds a master of law in securities regulation from Georgetown University Law Center, a juris doctor, cum laude, from New York law school and a bachelor of arts from Bucknell University.

About Netramark Holdings Inc.

Netramark is focused on being a leader in the development of generative artificial intelligence/machine learning solutions that are targeted at the biotechnology and pharmaceutical industries. The company's product offering uses a novel topology-based algorithm that has the ability to parse patient data sets into subsets of people that are strongly related according to several variables simultaneously. This allows Netramark to use a variety of ML methods, depending on the character and size of the data, to transform the data into powerfully intelligent data that activates traditional AI/ML methods. The result is that Netramark can work with much smaller data sets often prevalent in clinical trials and accurately segment diseases into different types, as well as help to classify patients for sensitivity to drugs and/or efficacy of treatment.

We seek Safe Harbor.